Heterozygous nonsense variants in the ferritin heavy-chain gene FTH1 cause a neuroferritinopathy.
Heterozygous nonsense variants in the ferritin heavy-chain gene FTH1 cause a neuroferritinopathy.
复制标题
DOI:
10.1016/j.xhgg.2023.100236
复制
发表时间:
2023-10-12
期刊:
影响因子:
--
通讯作者:
Ortiz-Gonzalez, Xilma R.
中科院分区:
文献类型:
--
作者:
Shieh, Joseph T.;Tintos-Hernandez, Jesus A.;Murali, Chaya N.;Penon-Portmann, Monica;Flores-Mendez, Marco;Santana, Adrian;Bulos, Joshua A.;Du, Kang;Dupuis, Lucie;Damseh, Nadirah;Mendoza-Londono, Roberto;Berera, Camilla;Lee, Julieann C.;Phillips, Joanna J.;Alves, Cesar A. P. F.;Dmochowski, Ivan J.;Ortiz-Gonzalez, Xilma R.
Ferritin, the iron-storage protein, is composed of light- and heavy-chain subunits, encoded by FTL and FTH1, respectively. Heterozygous variants in FTL cause hereditary neuroferritinopathy, a type of neurodegeneration with brain iron accumulation (NBIA). Variants in FTH1 have not been previously associated with neurologic disease. We describe the clinical, neuroimaging, and neuropathology findings of five unrelated pediatric patients with de novo heterozygous FTH1 variants. Children presented with developmental delay, epilepsy, and progressive neurologic decline. Nonsense FTH1 variants were identified using whole-exome sequencing, with a recurrent variant (p.Phe171∗) identified in four unrelated individuals. Neuroimaging revealed diffuse volume loss, features of pontocerebellar hypoplasia, and iron accumulation in the basal ganglia. Neuropathology demonstrated widespread ferritin inclusions in the brain. Patient-derived fibroblasts were assayed for ferritin expression, susceptibility to iron accumulation, and oxidative stress. Variant FTH1 mRNA transcripts escape nonsense-mediated decay (NMD), and fibroblasts show elevated ferritin protein levels, markers of oxidative stress, and increased susceptibility to iron accumulation. C-terminal variants in FTH1 truncate ferritin’s E helix, altering the 4-fold symmetric pores of the heteropolymer, and likely diminish iron-storage capacity. FTH1 pathogenic variants appear to act by a dominant, toxic gain-of-function mechanism. The data support the conclusion that truncating variants in the last exon of FTH1 cause a disorder in the spectrum of NBIA. Targeted knockdown of mutant FTH1 transcript with antisense oligonucleotides rescues cellular phenotypes and suggests a potential therapeutic strategy for this pediatric neurodegenerative disorder. This report describes how de novo variants in FTH1, encoding ferritin heavy chain, are linked to a pediatric disease in the spectrum of neurodegeneration with brain iron accumulation (NBIA). Our data suggest that C-terminal variants truncating the E helix of the ferritin heavy chain lead to brain ferritin accumulation and cellular oxidative stress, which can be ameliorated by antisense oligonucleotides.
登录
查看更多内容
影响因子:
6.1
作者:
Maccarinelli F;Pagani A;Cozzi A;Codazzi F;Di Giacomo G;Capoccia S;Rapino S;Finazzi D;Politi LS;Cirulli F;Giorgio M;Cremona O;Grohovaz F;Levi S
通讯作者:
Levi S
影响因子:
3.1
作者:
Davalieva, Katarina;Kiprijanovska, Sanja;Plaseska-Karanfilska, Dijana
通讯作者:
Plaseska-Karanfilska, Dijana
影响因子:
3.5
作者:
Lee, J. -H.;Gregory, A.;Hayflick, S. J.
通讯作者:
Hayflick, S. J.
影响因子:
2.7
作者:
Ingrassia, Rosaria;Gerardi, Gianmario;Arosio, Paolo
通讯作者:
Arosio, Paolo
影响因子:
2.6
作者:
Kato, Junji;Kobune, Masayoshi;Niitsu, Yoshiro
通讯作者:
Niitsu, Yoshiro